Aliquots Archives
Stomach bug alters tumor suppressor
Oct. 23, 2012—The stomach bug Helicobacter pylori increases forms of a protein that promote tumor development, perhaps explaining how it elevates risk for gastric cancer.
More gene links to breast cancer risk
Oct. 19, 2012—Two newly identified gene variants linked to breast cancer may aid in predicting disease risk and targeting screening and prevention strategies.
Setting traps to probe gene function
Oct. 18, 2012—A new method for creating genetic mutations that can be activated at certain times or in specific tissues will enable studies to probe gene function.
Amish aid search for Alzheimer’s genes
Oct. 11, 2012—An analysis of Amish populations revealed novel risk genes for late-onset Alzheimer disease.
Complementary and alternative medicine use differs by race, economics
Oct. 9, 2012—Use of complementary and alternative medicine differs by race and socioeconomic factors, study reports.
Host proteins can control HIV infection
Oct. 5, 2012—The protein APOBEC3G contributes to spontaneous control of HIV-1 in vivo and may provide therapeutic benefits.
An orphan enzyme’s purpose
Oct. 4, 2012—“Orphan” enzyme may play role in cancer growth, new research suggests.
Target acquired for aggressive tumor
Sep. 27, 2012—New therapeutic target for angiosarcoma – an aggressive, highly fatal tumor of the blood vessels – identified.
Cell entry ports for cold virus
Sep. 25, 2012—The respiratory virus HMPV uses its fusion (F) protein – which interacts with cellular receptors called integrins – to bind to and enter target cells.
HER2 may impact lung cancer therapy
Sep. 21, 2012—A protein associated with aggressive breast cancers may also influence resistance of lung cancer to targeted therapies.
How ‘Jedi’ disposes of dead neurons
Sep. 19, 2012—The protein Syk is essential for clearing away neuron “corpses” in the developing peripheral nervous system.
Cells with LIP eat their neighbors
Sep. 13, 2012—A transcription factor called LIP is capable of causing one cell to consume another.
